A. Hanssen

Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer

K. Pantel, K. Effenberger, M. Bockhorn, 2018, Clinical Cancer Research.

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer

K. Pantel, S. Loges, H. Wikman, 2015, Front. Oncol..

Loss of 4q21.23-22.1 Is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer

G. Sauter, R. Simon, J. Izbicki, 2014, PloS one.

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients

M. Westphal, K. Pantel, S. Riethdorf, 2019, Scientific Reports.

Identification of a High-Level MET Amplification in CTCs and cfTNA of an ALK-Positive NSCLC Patient Developing Evasive Resistance to Crizotinib.

M. Tiemann, G. Sauter, C. Bokemeyer, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clonality of circulating tumor cells in breast cancer brain metastasis patients

M. Westphal, S. Sauer, K. Pantel, 2019, Breast Cancer Research.

Characterization of different CTC subpopulations in non-small cell lung cancer

D. Atanackovic, K. Pantel, W. Knoefel, 2016, Scientific Reports.

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease

M. Westphal, K. Pantel, S. Riethdorf, 2018, Cancers.

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients

M. Westphal, K. Pantel, S. Riethdorf, 2019, Scientific Reports.

Clonality of circulating tumor cells in breast cancer brain metastasis patients

M. Westphal, S. Sauer, K. Pantel, 2019, Breast Cancer Research.

HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis

I. Paatero, H. Wikman, T. Schinke, 2024, Journal of experimental & clinical cancer research : CR.